Articles

1. Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan

   • Chun-Chi Yang
   • Chung-Feng Huang
   • Ming-Lung Yu

   Original Research Open access 28 April 2024

   

2. Correction to: Virologic Outcomes with Molnupiravir in Nonhospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial

   • Julie M. Strizki
   • Jay A. Grobler
   • Carisa De Anda

   Correction Open access 25 April 2024

3. Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis

   • Tetsuya Matsumoto
   • Akira Yuasa
   • Naohiro Yonemoto

   Original Research Open access 25 April 2024

   

4. Modelling COVID-19 Vaccination in the UK: Impact of the Autumn 2022 and Spring 2023 Booster Campaigns

   • Diana Mendes
   • Sheeja Machira Krishnan
   • Jingyan Yang

   Original Research Open access 25 April 2024

   

5. Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK

   • Alen Marijam
   • Nikki Vroom
   • Hilde Vroling

   Original Research Open access 24 April 2024

   

6. Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study

   • Marta Colaneri
   • Camilla Genovese
   • Andrea Gori

   Brief Report Open access 21 April 2024

7. Underlying Neural Mechanisms of Cognitive Improvement in Fronto-striatal Response Inhibition in People Living with HIV Switching Off Efavirenz: A Randomized Controlled BOLD fMRI Trial

   • Patrick G. A. Oomen
   • Charlotte S. Hakkers
   • Stefan du Plessis

   Original Research Open access 20 April 2024

   

8. Fungal Prosthetic Joint Infection: A Case Series and Review of the Literature

   • Victoria Starnes
   • Joan Duggan
   • Caitlyn Hollingshead

   Original Research Open access 13 April 2024

   

9. Effect of Regdanvimab on Mortality in Patients Infected with SARS-CoV-2 Delta Variants: A Propensity Score-Matched Cohort Study

   • Soyoon Hwang
   • Nan Young Lee
   • Ki Tae Kwon

   Original Research Open access 12 April 2024

   

10. Ritonavir: 25 Years’ Experience of Concomitant Medication Management. A Narrative Review

    • Romina Quercia
    • Giovanni Di Perri
    • Marta Boffito

    Review Open access 12 April 2024

11. Systematic Review of Heel Puncture-Related Osteomyelitis of the Calcaneus in Newborn Infants

    • Vidmi Taolam Martin
    • Ismail Ahmed Dhagey
    • Bin Yu

    Review Open access 08 April 2024

    

12. Structured Literature Review to Identify Human Papillomavirus’s Natural History Parameters for Dynamic Population Models of Vaccine Impacts

    • Ibrahim Diakite
    • Bruno Martins
    • Elamin Elbasha

    Review Open access 08 April 2024

    

13. Seroprevalence and Shifting Endemicities of Hepatitis A Virus Infection in Two Different Geographical Areas in the Philippines

    • Josefina C. Carlos
    • Vinna Marie T. Quinones
    • Adriana Guzman-Holst

    Original Research Open access 05 April 2024

    

14. Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany

    • Sebastian Gruhn
    • Manuel Batram
    • Oliver Damm

    Original Research Open access 04 April 2024 Pages: 907 - 920

    

15. Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study

    • Stefan Schneider
    • Gary Blick
    • Alan Oglesby

    Original Research Open access 03 April 2024 Pages: 891 - 906

    

16. Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses

    • Paul Benson
    • Jennifer Kuretski
    • Alan Oglesby

    Original Research Open access 03 April 2024 Pages: 875 - 889

    

17. Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations

    • Alexy Inciarte
    • Lorena de la Mora
    • Josep Mallolas

    Case Report Open access 03 April 2024 Pages: 647 - 658

    

18. Impact of Immunosuppressed Status on Prognosis of Carbapenem-Resistant Organisms Bloodstream Infections

    • Yuan-Yuan Li
    • Yan Chen
    • Bin Du

    Original Research Open access 27 March 2024 Pages: 861 - 874

    

19. Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019

    • Aleksandra Polkowska-Kramek
    • Elizabeth Begier
    • Gernot Rohde

    Original Research Open access 23 March 2024 Pages: 845 - 860

20. Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States

    • Daniel Molnar
    • Elizabeth M. La
    • Desmond Curran

    Original Research Open access 20 March 2024 Pages: 827 - 844

    

21. Estimation of Symptomatic Respiratory Syncytial Virus Infection Incidence in Adults in Multiple Countries: A Time-Series Model-Based Analysis Protocol

    • Robin Bruyndonckx
    • Aleksandra Polkowska-Kramek
    • Elizabeth Begier

    Study Protocol Open access 18 March 2024 Pages: 953 - 963

22. Best Practices for Identifying Hospitalized Lower Respiratory Tract Infections Using Administrative Data: A Systematic Literature Review of Validation Studies

    • Germaine Hanquet
    • Christian Theilacker
    • Elizabeth Begier

    Review Open access 18 March 2024 Pages: 921 - 940

    

23. Evaluating the Demand for Nucleic Acid Testing in Different Scenarios of COVID-19 Transmission: A Simulation Study

    • Yu-Yuan Wang
    • Wei-Wen Zhang
    • Ming-xia Jing

    Original Research Open access 18 March 2024 Pages: 813 - 826

    

24. Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework

    • Sushma Kavikondala
    • Katrin Haeussler
    • Ekkehard Beck

    Original Research Open access 18 March 2024 Pages: 779 - 811

    

25. Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia

    • Ru Han
    • Peter San Martin
    • Désirée A. M. van Oorschot

    Original Research Open access 17 March 2024 Pages: 761 - 778

    

26. Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical Conditions

    • Mark H. Rozenbaum
    • Erica Chilson
    • Mark Atwood

    Original Research Open access 16 March 2024 Pages: 745 - 760

    

27. Distinct Lipidomic Profiles between People Living with HIV Treated with E/C/F/TAF or B/F/TAF: An Open-Label Prospective Cohort Study

    • Zhikai Wan
    • Junwei Su
    • Biao Zhu

    Original Research Open access 15 March 2024 Pages: 727 - 744

    

28. K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact

    • Carolina Garcia-Vidal
    • Christian Teijón-Lumbreras
    • Alex Soriano

    Original Research Open access 15 March 2024 Pages: 715 - 726

    

29. Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination

    • Timothy E. Albertson
    • Caitlin Hansen
    • the C4591031, C4591007 Clinical Trial Groups

    Original Research Open access 15 March 2024 Pages: 699 - 714

    

30. Effect of Infusion Set Replacement Intervals on Central Line-Associated Bloodstream Infection in the Intensive Care Unit: Study Protocol of the INSPIRATION Study

    • Dandan Xu
    • Chang Hu
    • On behalf of the INSPIRATION Study group

    Study Protocol Open access 14 March 2024 Pages: 941 - 951

    

31. Household Influenza Transmission and Healthcare Resource Utilization Among Patients Treated with Baloxavir vs Oseltamivir: A United States Outpatient Prospective Survey

    • Jennie H. Best
    • Mitra Sadeghi
    • Marcus J. Zervos

    Original Research Open access 14 March 2024 Pages: 685 - 697

    

32. Podcast: Need for Quality Evidence for Decision-Making on Seasonal Influenza Vaccines

    • Ann R. Falsey
    • Stefania Maggi
    • Tor Biering-Sørensen

    Commentary Open access 14 March 2024 Pages: 659 - 666

33. Epidemiology of Reportable Bacterial Infectious Diseases in Saudi Arabia

    • Nada K. Alhumaid
    • Areej M. Alajmi
    • Essam A. Tawfik

    Original Research Open access 10 March 2024 Pages: 667 - 684

34. Longitudinal Molecular and Serological Evidence of SARS-CoV-2 Infections and Vaccination Status: Community-Based Surveillance Study (CONTACT)

    • Olga Sánchez-Soliño
    • Ryan D. Kilpatrick
    • Gregory C. Gray

    Brief Report Open access 10 March 2024 Pages: 633 - 645

    

35. Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor

    • Takayuki Katsube
    • Safwan Kezbor
    • Ryuji Kubota

    Original Research Open access 09 March 2024 Pages: 597 - 607

    

36. Clinical Characteristics of Uncomplicated Acute Pyelonephritis Caused by Escherichia coli and Klebsiella pneumoniae

    • Miri Hyun
    • Ji Yeon Lee
    • Hyun ah Kim

    Original Research Open access 09 March 2024 Pages: 581 - 595

    

37. Amoebic Liver Abscess: Potential Application of New Diagnostic Techniques for an Old Pathogen

    • Federica Portunato
    • Claudia Bartalucci
    • Matteo Bassetti

    Case Report Open access 08 March 2024 Pages: 625 - 632

    

38. Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from France

    • Elise Foudrat
    • Sophie Caillard

    Commentary Open access 08 March 2024 Pages: 439 - 445

39. The Impact of the COVID-19 Pandemic on the Incidence of Herpes Zoster: A Narrative Literature Review

    • Raunak Parikh
    • Mitra Yousefi
    • Robyn Widenmaier

    Review Open access 05 March 2024 Pages: 447 - 461

    

40. 4CMenB Vaccination to Prevent Meningococcal B Disease in Vietnam: Expert Review and Opinion

    • Nguyen Phung Nguyen The
    • Pham Quang Thai
    • Nguyen Hoan Le Minh

    Commentary Open access 02 March 2024 Pages: 423 - 437

    

41. Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study

    • Nicholas Rebold
    • Sara Alosaimy
    • Michael J. Rybak

    Original Research Open access 01 March 2024 Pages: 565 - 579

    

42. Direct-Acting Antivirals Remain Cost-Effective Treatments for Chronic Hepatitis C in Australia Despite Changes to the Treated Population and the Availability of Retreatment: The Glecaprevir/Pibrentasvir (Maviret^®) Example

    • Emma Warren
    • Belinda J. C. Castles
    • Aitor Arteaga

    Original Research Open access 01 March 2024 Pages: 549 - 564

    

43. Oritavancin Versus Daptomycin for Osteomyelitis Treatment After Surgical Debridement

    • Nicholas W. Van Hise
    • Russell M. Petrak
    • Mark Redell

    Original Research Open access 29 February 2024 Pages: 535 - 547

44. Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Trial

    • F. D. Richard Hobbs
    • Hugh Montgomery
    • Mark T. Esser

    Original Research Open access 25 February 2024 Pages: 521 - 533

    

45. Surgical Treatment of Persistent Pseudomonas aeruginosa Bacteraemia After n-Butyl-2-cyanoacrylate for Gastric Bleeding Varices

    • Abiu Sempere
    • Gabriela Chullo
    • Marta Bodro

    Case Report Open access 23 February 2024 Pages: 619 - 624

    

46. A Population-Based Study on the Incidence, Risk Factors, and Outcome of Salmonella Bloodstream Infections in South Sweden 2012–2022

    • L. Björklund
    • Y. Mattisson
    • O. Ljungquist

    Original Research Open access 23 February 2024 Pages: 501 - 519

    

47. Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study

    • Juan Ambrosioni
    • Natalia Anahí Díaz
    • Jose Molto

    Brief Report Open access 19 February 2024 Pages: 609 - 617

    

48. Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach

    • Florian Zeevat
    • Joost J. M. Simons
    • Maarten J. Postma

    Original Research Open access 16 February 2024 Pages: 481 - 499

    

49. Publisher Correction: Podcast: Influenza-Associated Complications and the Impact of Vaccination on Public Health

    • Stefania Maggi
    • Melissa K. Andrew
    • Annemarijn de Boer

    Publisher Correction Open access 16 February 2024 Pages: 421 - 421

50. A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States

    • Jennifer Eeuwijk
    • Gui Ferreira
    • Mirna Robert-Du Ry van Beest Holle

    Review Open access 13 February 2024 Pages: 273 - 298